Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent
Intraperitoneal (IP) chemotherapy is an effective way of treating peritoneal carcinomatosis of colorectal origin after complete cytoreduction. Although IP therapy has been already performed for many years, no standardized treatment design has been developed in terms of schedule, residence time, drug...
Saved in:
| Main Authors: | L. De Smet, W. Ceelen, J. P. Remon, C. Vervaet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2013/720858 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiotoxicity in chemotherapeutic agents
by: Vitorino Modesto dos Santos, et al.
Published: (2021-03-01) -
Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells
by: Mohammad Shahpouri, et al.
Published: (2024-10-01) -
Investigating the Potential of Extracellular Vesicles as Delivery Systems for Chemotherapeutics
by: Alessia Brancolini, et al.
Published: (2024-12-01) -
Comparison of three-bag and single-bag protocols in rapid drug desensitization with chemotherapeutic and biological agents
by: Ozcan Gul, MD, et al.
Published: (2025-07-01) -
Taxane Group of Chemotherapeutic Agent and Acute Coronary Syndrome
by: Roop Kaur Gill, et al.
Published: (2021-01-01)